In another case, by targeting collagen VI alpha 6 chain (COL6A6) with a specific human scFv, researchers achieved a 45% regression in atherosclerosis in ApoE−/− mice, evidenced by aorta staining. The gene discussed is APOE; the disease is atherosclerosis.